Litcius/Paper detail

A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity

Wenqiang Shi, Liangyin Lv, Nan Liu, Hui Wang, Yang Wang, Wen Zhu, Zexin Liu, Jianwei Zhu, Huili Lu

2022Molecular Therapy33 citationsDOIOpen Access PDF

Topics & Concepts

Tumor microenvironmentBlockadeImmune systemImmune checkpointCancer researchCytokineImmunotherapyPD-L1MedicineImmunologyReceptorInternal medicineImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersCAR-T cell therapy research
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity | Litcius